We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Women using modafinil are being warned of an increased risk of birth defects associated with modafinil use during pregnancy.
First published during the 2019 to 2022 Johnson Conservative government
The Yellow Card scheme is the UK’s system for reporting suspected side effects to medicines and adverse events with medical devices run by the Medicines and Healthcare products Regulatory Agency (MHRA).
Stronger warnings about the risk of dependence and addiction to be added to the patient information leaflet and discussed with patients
The MHRA will now issue all safety-critical alerts for medicines and medical devices that require action as National Patient Safety Alerts
People who take stimulant laxatives for constipation are being advised that these will now be sold in smaller packs, with on-pack warnings.
Warning that thermal cameras and other such “temperature screening” products, some of which make direct claims to screen for COVID-19, are not a reliable way to detect if people have the virus.
Allergy patients who carry Emerade 500 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand.
Patients are urged to stop taking 5mg ulipristal acetate as soon as possible and contact a healthcare professional for advice on alternative treatments.
The Medicines and Healthcare products Regulatory Agency (MHRA) launches a week long social media campaign to raise awareness about the importance of reporting suspected side effects using the Yellow Card Scheme.
MHRA update on metformin medicines.
A drug alert has been issued to retailers and healthcare professionals as 4 companies are recalling batches of certain over-the-counter Ranitidine medicines used to treat conditions such as stomach ulcers and heartburn.
Ranitidine – MHRA drug alert issued as Creo Pharma Limited and Tillomed Laboratories recall unexpired stock
The MHRA has issued alerts to healthcare professionals and retailers, as Perrigo Company plc is recalling all unexpired stock of certain batches of Ranitidine medicines used to treat conditions such as heartburn and stomach …
As a precautionary measure, patients taking certain types of prescription-only medicines for Parkinson’s (Neupro) and epilepsy (Vimpat) are asked to check to see if they have products from batches of medicines which are bein…
As a precautionary measure, patients taking certain types of prescription-only medicines for Parkinson’s (Neupro), epilepsy (Vimpat) and blood clots (Clexane) are asked to check to see if they have products from batches of m…
MHRA has recalled 3 batches of Losartan tablets due to contamination with the nitrosamine N-nitroso-N-methylamino butyric acid.
Pharmacies across the UK are working with us to recall blood pressure and heart medication as a precaution.
People who have purchased Clear & Simple Digital Pregnancy Tests are advised to check the lot number after some tests have returned inaccurate results.
Certain batches of four homeopathic products manufactured in the USA have been voluntarily recalled due to possible microbial contamination.
Anyone using affected batches are advised to stop use over concerns they do not meet safety standards.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).